# Descemet Endothelial Thickness Comparison Trial I

> **NCT05289661** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Stanford University** · enrollment: 160 (actual)

## Conditions studied

- Fuchs

## Interventions

- **DRUG:** Topical Ripasudil
- **DRUG:** Topical Placebo

## Key facts

- **NCT ID:** NCT05289661
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-07-15
- **Primary completion:** 2026-11-30
- **Final completion:** 2027-11-30
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2026-05-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05289661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05289661, "Descemet Endothelial Thickness Comparison Trial I". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT05289661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*